secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptose Biosciences Inc. (APTOF)
CIK:        0000882361
Form:       8-K
Filed at:   2022-11-25T23:59:59+00:00
Accession:  0001171843-22-007660
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Aptose terminates $75M ATM equity distribution agreement with Piper Sandler and Canaccord
--------------------------------------------------------------------------------

- Terminated Equity Distribution Agreement dated May 5, 2020, effective Nov 18, 2022.
- No penalties associated with termination; company no longer intends to use facility.
- Prior to termination, only ~$86K in net proceeds raised from the $75M facility.
- Placement agents were Piper Sandler & Co. and Canaccord Genuity LLC.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882361/000117184322007660/0001171843-22-007660-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882361/000117184322007660/f8k_112522.htm
  HTML page:      https://secwatch.observer/filing/0001171843-22-007660

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer